InsidersTradesSigma
Track the Alligator Bioscience AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Alligator Bioscience AB has recorded 3 public disclosures. Market capitalisation: €140.7m. The latest transaction was disclosed on 24 December 2025 (Purchase). Among the most active insiders: Peter Ostler. All data is openly available.
Analysts rate Alligator Bioscience AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 0.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations